ProCE Banner Activity

Key HIV Studies Influencing My Practice Following AIDS 2024—Drs Chloe Orkin and Monica Gandhi

Conference Coverage
Video

Hear from expert faculty as they discuss their insights on some of the most clinically relevant new data presented at AIDS 2024, covering studies on oral PrEP, ART switch strategies, and cardiovascular risk reduction among people with HIV.

Released: August 15, 2024

Expiration: August 14, 2025

Share

Faculty

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities – Queen Mary University of London
Dean for Healthcare Transformation – Queen Mary University of London
Honorary Consultant Physician – Barts Health NHS Trust
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC in partnership with the International AIDS Society  

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Partners

IAS

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection. 

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in applying new findings to optimize treatment and prevention strategies for HIV infection. 

Learning Objectives

Upon completion of this activity, participants should be able to: 

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

Monica Gandhi, MD, MPH

Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco 
San Francisco, California

Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities – Queen Mary University of London
Dean for Healthcare Transformation – Queen Mary University of London
Honorary Consultant Physician – Barts Health NHS Trust
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GlaxoSmithKline, Merck Sharp & Dohme, ViiV.